{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:29:52Z","timestamp":1787027392484,"version":"build-2736575974"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:00:00Z","timestamp":1710720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontierspartnerships.org"],"crossmark-restriction":true},"short-container-title":["Transpl Int"],"abstract":"<jats:p>The International Immunosuppression and Transplant Skin Cancer Collaborative (ITSCC) and its European counterpart, Skin Care in Organ Transplant Patients-Europe (SCOPE) are comprised of physicians, surgeons, and scientist who perform integrative collaborative research focused on cutaneous malignancies that arise in solid organ transplant recipients (SOTR) and patients with other forms of long-term immunosuppression. In October 2022, ITSCC held its biennial 4-day scientific symposium in Essex, Massachusetts. This meeting was attended by members of both ITSCC and SCOPE and consisted of specialists including Mohs micrographic and dermatologic oncology surgeons, medical dermatologists, transplant dermatologists, transplant surgeons, and transplant physicians. During this symposium scientific workshop groups focusing on consensus standards for case reporting of retrospective series for invasive squamous cell carcinoma (SCC), defining immunosuppressed patient status for cohort reporting, development of multi-institutional registry for reporting rare tumors, and development of a KERACON clinical trial of interventions after a SOTRs\u2019 first cutaneous SCC were developed. The majority of the symposium focused on presentation of the most up to date research in cutaneous malignancy in SOTR and immunosuppressed patients with specific focus on chemoprevention, immunosuppression regimens, immunotherapy in SOTRs, spatial transcriptomics, and the development of cutaneous tumor registries. Here, we present a summary of the most impactful scientific updates presented at the 2022 ITSCC symposium.<\/jats:p>","DOI":"10.3389\/ti.2024.12387","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:11:22Z","timestamp":1710720682000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Updates in Skin Cancer in Transplant Recipients and Immunosuppressed Patients: Review of the 2022\u20132023 Scientific Symposium of the International Immunosuppression and Transplant Skin Cancer Collaborative"],"prefix":"10.3389","volume":"37","author":[{"given":"Catherine","family":"Pisano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin J.","family":"Leitenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Pugliano-Mauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan T.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1001\/jamadermatol.2017.2984","article-title":"Long-Term Change in the Risk of Skin Cancer After Organ Transplantation: A Population-Based Nationwide Cohort Study","volume":"153","author":"Rizvi","year":"2017","journal-title":"JAMA Dermatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1001\/jamadermatol.2021.3180","article-title":"Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Delphi Consensus Statement","volume":"157","author":"Massey","year":"2021","journal-title":"JAMA Dermatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1111\/tri.13520","article-title":"Initial Skin Cancer Screening for Solid Organ Transplant Recipients in the United States: Delphi Method Development of Expert Consensus Guidelines","volume":"32","author":"Crow","year":"2019","journal-title":"Transpl Int"},{"key":"B4","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1365-2133.2009.09453.x","article-title":"Prevention of Non-Melanoma Skin Cancer in Organ Transplant Patients by Regular Use of a Sunscreen: A 24 Months, Prospective, Case-Control Study","volume":"161","author":"Ulrich","year":"2009","journal-title":"Br J Dermatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1200\/JCO.1995.13.8.1933","article-title":"Prevention of Skin Cancer and Reduction of Keratotic Skin Lesions During Acitretin Therapy in Renal Transplant Recipients: A Double-Blind, Placebo-Controlled Study","volume":"13","author":"Bavinck","year":"1995","journal-title":"J Clin Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1046\/j.1440-0960.2002.00613.x","article-title":"Acitretin for Chemoprevention of Non-Melanoma Skin Cancers in Renal Transplant Recipients","volume":"43","author":"George","year":"2002","journal-title":"Australas J Dermatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.1038\/s41467-018-06027-1","article-title":"The Genomic Landscape of Cutaneous SCC Reveals Drivers and a Novel Azathioprine Associated Mutational Signature","volume":"9","author":"Inman","year":"2018","journal-title":"Nat Commun"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.3390\/ijms21082956","article-title":"Cutaneous Squamous Cell Carcinoma: From Biology to Therapy","volume":"21","author":"Corchado-Cobos","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"10880","DOI":"10.3389\/ti.2022.10880","article-title":"Interventions After First Post-Transplant Cutaneous Squamous Cell Carcinoma: A Proposed Decision Framework","volume":"35","author":"Bottomley","year":"2022","journal-title":"Transpl Int"},{"key":"B10","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1684\/ejd.2021.4108","article-title":"The Association Between Immunosuppression and Skin Cancer in Solid Organ Transplant Recipients: A Control-Matched Cohort Study of 2, 852 Patients","volume":"31","author":"Gibson","year":"2021","journal-title":"Eur J Dermatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.healun.2018.03.012","article-title":"Azathioprine to Mycophenolate Mofetil Transition and Risk of Squamous Cell Carcinoma After Lung Transplantation","volume":"37","author":"Vos","year":"2018","journal-title":"J Heart Lung Transpl"},{"key":"B12","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.jaad.2019.09.070","article-title":"Belatacept Reduces Skin Cancer Risk in Kidney Transplant Recipients","volume":"82","author":"Wang","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1097\/TP.0000000000004459","article-title":"Immune Checkpoint Inhibitors in Solid Organ Transplant Recipients With Advanced Skin Cancers-Emerging Strategies for Clinical Management","volume":"107","author":"Ferr\u00e1ndiz-Pulido","year":"2023","journal-title":"Transplantation"},{"key":"B14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s40425-019-0585-1","article-title":"Checkpoint Inhibitor Therapy for Cancer in Solid Organ Transplantation Recipients: An Institutional Experience and a Systematic Review of the Literature","volume":"7","author":"Abdel-Wahab","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejca.2020.01.008","article-title":"European Interdisciplinary Guideline on Invasive Squamous Cell Carcinoma of the Skin: Part 2. Treatment","volume":"128","author":"Stratigos","year":"2020","journal-title":"Eur J Cancer Oxf Engl 1990"},{"key":"B16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.det.2019.03.001","article-title":"Merkel Cell Carcinoma: Updates on Staging and Management","volume":"37","author":"Cornejo","year":"2019","journal-title":"Dermatol Clin"},{"key":"B17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2217\/fon-2019-0762","article-title":"CASE (CemiplimAb-Rwlc Survivorship and Epidemiology) Study in Advanced Cutaneous Squamous Cell Carcinoma","volume":"16","author":"Migden","year":"2020","journal-title":"Future Oncol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"9547","DOI":"10.1200\/jco.2021.39.15_suppl.9547","article-title":"Checkpoint Inhibition in Immunosuppressed or Immunocompromised Patients With Advanced Cutaneous Squamous Cell Carcinoma (CSCC): Data From Prospective CemiplimAb-Rwlc Survivorship and Epidemiology (C.A.S.E.) Study","volume":"39","author":"Rabinowits","year":"2021","journal-title":"J Clin Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1019111","DOI":"10.3389\/fonc.2022.1019111","article-title":"Spatial Transcriptomics Technology in Cancer Research","volume":"12","author":"Yu","year":"2022","journal-title":"Front Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"6278","DOI":"10.1038\/s41467-021-26614-z","article-title":"Spatially Resolved Transcriptomics Reveals the Architecture of the Tumor-Microenvironment Interface","volume":"12","author":"Hunter","year":"2021","journal-title":"Nat Commun"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1681\/ASN.2015030250","article-title":"CD8+ Immunosenescence Predicts Post-Transplant Cutaneous Squamous Cell Carcinoma in High-Risk Patients","volume":"27","author":"Bottomley","year":"2016","journal-title":"J Am Soc Nephrol"}],"container-title":["Transplant International"],"original-title":[],"link":[{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/ti.2024.12387\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:11:25Z","timestamp":1710720685000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/ti.2024.12387\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,18]]},"references-count":21,"alternative-id":["10.3389\/ti.2024.12387"],"URL":"https:\/\/doi.org\/10.3389\/ti.2024.12387","relation":{},"ISSN":["1432-2277"],"issn-type":[{"value":"1432-2277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,18]]},"article-number":"12387"}}